nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—PTPN4—hindbrain—epilepsy syndrome	0.0189	0.0702	CbGeAlD
Alendronate—PTPRS—hindbrain—epilepsy syndrome	0.0162	0.0602	CbGeAlD
Alendronate—ATP6V1A—ganglion—epilepsy syndrome	0.0123	0.0458	CbGeAlD
Alendronate—PTPN4—brainstem—epilepsy syndrome	0.0109	0.0403	CbGeAlD
Alendronate—PTPRE—telencephalon—epilepsy syndrome	0.0101	0.0376	CbGeAlD
Alendronate—PTPN4—telencephalon—epilepsy syndrome	0.00963	0.0357	CbGeAlD
Alendronate—ATP6V1A—hindbrain—epilepsy syndrome	0.00936	0.0347	CbGeAlD
Alendronate—PTPRS—brainstem—epilepsy syndrome	0.0093	0.0345	CbGeAlD
Alendronate—PTPRS—forebrain—epilepsy syndrome	0.00898	0.0333	CbGeAlD
Alendronate—PTPRS—telencephalon—epilepsy syndrome	0.00826	0.0306	CbGeAlD
Alendronate—PTPRE—midbrain—epilepsy syndrome	0.00727	0.027	CbGeAlD
Alendronate—PTPRE—head—epilepsy syndrome	0.00631	0.0234	CbGeAlD
Alendronate—PTPN4—head—epilepsy syndrome	0.006	0.0222	CbGeAlD
Alendronate—PTPRE—nervous system—epilepsy syndrome	0.00598	0.0222	CbGeAlD
Alendronate—PTPRS—spinal cord—epilepsy syndrome	0.00578	0.0215	CbGeAlD
Alendronate—PTPRE—central nervous system—epilepsy syndrome	0.00576	0.0213	CbGeAlD
Alendronate—PTPN4—nervous system—epilepsy syndrome	0.00569	0.0211	CbGeAlD
Alendronate—PTPRE—cerebellum—epilepsy syndrome	0.00563	0.0209	CbGeAlD
Alendronate—PTPN4—central nervous system—epilepsy syndrome	0.00547	0.0203	CbGeAlD
Alendronate—ATP6V1A—brainstem—epilepsy syndrome	0.00536	0.0199	CbGeAlD
Alendronate—PTPN4—cerebellum—epilepsy syndrome	0.00535	0.0198	CbGeAlD
Alendronate—ATP6V1A—forebrain—epilepsy syndrome	0.00518	0.0192	CbGeAlD
Alendronate—PTPRS—head—epilepsy syndrome	0.00514	0.0191	CbGeAlD
Alendronate—PTPRS—nervous system—epilepsy syndrome	0.00487	0.0181	CbGeAlD
Alendronate—ATP6V1A—telencephalon—epilepsy syndrome	0.00476	0.0177	CbGeAlD
Alendronate—PTPRS—central nervous system—epilepsy syndrome	0.00469	0.0174	CbGeAlD
Alendronate—PTPRS—cerebellum—epilepsy syndrome	0.00459	0.017	CbGeAlD
Alendronate—PTPRE—brain—epilepsy syndrome	0.00457	0.0169	CbGeAlD
Alendronate—PTPN4—brain—epilepsy syndrome	0.00435	0.0161	CbGeAlD
Alendronate—Histamine Phosphate—HRH3—epilepsy syndrome	0.00426	0.388	CrCbGaD
Alendronate—FDPS—forebrain—epilepsy syndrome	0.0039	0.0145	CbGeAlD
Alendronate—ATP6V1A—medulla oblongata—epilepsy syndrome	0.00374	0.0139	CbGeAlD
Alendronate—PTPRS—brain—epilepsy syndrome	0.00373	0.0138	CbGeAlD
Alendronate—FDPS—telencephalon—epilepsy syndrome	0.00359	0.0133	CbGeAlD
Alendronate—Histamine Phosphate—CA4—epilepsy syndrome	0.00358	0.326	CrCbGaD
Alendronate—ATP6V1A—midbrain—epilepsy syndrome	0.00342	0.0127	CbGeAlD
Alendronate—ATP6V1A—spinal cord—epilepsy syndrome	0.00334	0.0124	CbGeAlD
Alendronate—ATP6V1A—head—epilepsy syndrome	0.00296	0.011	CbGeAlD
Alendronate—FDPS—medulla oblongata—epilepsy syndrome	0.00282	0.0105	CbGeAlD
Alendronate—ATP6V1A—nervous system—epilepsy syndrome	0.00281	0.0104	CbGeAlD
Alendronate—ATP6V1A—central nervous system—epilepsy syndrome	0.00271	0.01	CbGeAlD
Alendronate—ATP6V1A—cerebellum—epilepsy syndrome	0.00264	0.00981	CbGeAlD
Alendronate—FDPS—midbrain—epilepsy syndrome	0.00258	0.00955	CbGeAlD
Alendronate—FDPS—spinal cord—epilepsy syndrome	0.00251	0.00932	CbGeAlD
Alendronate—FDPS—head—epilepsy syndrome	0.00223	0.00828	CbGeAlD
Alendronate—ATP6V1A—brain—epilepsy syndrome	0.00215	0.00797	CbGeAlD
Alendronate—FDPS—nervous system—epilepsy syndrome	0.00212	0.00785	CbGeAlD
Alendronate—FDPS—central nervous system—epilepsy syndrome	0.00204	0.00756	CbGeAlD
Alendronate—FDPS—cerebellum—epilepsy syndrome	0.00199	0.00739	CbGeAlD
Alendronate—FDPS—brain—epilepsy syndrome	0.00162	0.006	CbGeAlD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.00133	0.00915	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.00133	0.00915	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—TSC1—epilepsy syndrome	0.00131	0.00906	CbGpPWpGaD
Alendronate—Risedronate—PTGS2—epilepsy syndrome	0.0012	0.109	CrCbGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.00118	0.00816	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.00118	0.00816	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.00118	0.00816	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—SIRT1—epilepsy syndrome	0.00115	0.00794	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—ADAM10—epilepsy syndrome	0.00114	0.00783	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.00108	0.00746	CbGpPWpGaD
Alendronate—Clodronate—PTGS2—epilepsy syndrome	0.00107	0.097	CrCbGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.000995	0.00686	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.000995	0.00686	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000946	0.00652	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000897	0.00618	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000897	0.00618	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000897	0.00618	CbGpPWpGaD
Alendronate—Histamine Phosphate—CYP2D6—epilepsy syndrome	0.00089	0.0809	CrCbGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000856	0.0059	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000856	0.0059	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—KDR—epilepsy syndrome	0.000779	0.00537	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—TSC2—epilepsy syndrome	0.000766	0.00528	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.000754	0.0052	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6ST—epilepsy syndrome	0.000704	0.00485	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000698	0.00481	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.00069	0.00475	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.00068	0.00469	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.00068	0.00469	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.000664	0.00458	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PDXK—epilepsy syndrome	0.000662	0.00456	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000649	0.00447	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—MTOR—epilepsy syndrome	0.000628	0.00433	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000622	0.00429	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000622	0.00429	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000622	0.00429	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000622	0.00429	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NHLRC1—epilepsy syndrome	0.000605	0.00417	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PNPO—epilepsy syndrome	0.000605	0.00417	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EPM2A—epilepsy syndrome	0.000605	0.00417	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—FGF2—epilepsy syndrome	0.000604	0.00416	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.000603	0.00416	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CA13—epilepsy syndrome	0.000585	0.00403	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000578	0.00398	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—FGF2—epilepsy syndrome	0.000569	0.00393	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SV2A—epilepsy syndrome	0.000563	0.00388	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000551	0.0038	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000543	0.00375	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000529	0.00364	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—MTOR—epilepsy syndrome	0.000518	0.00357	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000509	0.00351	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—CASP3—epilepsy syndrome	0.000506	0.00349	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PFKL—epilepsy syndrome	0.000502	0.00346	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000491	0.00339	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000491	0.00339	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—MMP9—epilepsy syndrome	0.000478	0.00329	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000471	0.00325	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.000471	0.00324	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—STX1B—epilepsy syndrome	0.000459	0.00316	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CERS1—epilepsy syndrome	0.000443	0.00305	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PDXK—epilepsy syndrome	0.000443	0.00305	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GLUD1—epilepsy syndrome	0.000443	0.00305	CbGpPWpGaD
Alendronate—FDPS—Metabolism—FAR1—epilepsy syndrome	0.000443	0.00305	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ADK—epilepsy syndrome	0.000443	0.00305	CbGpPWpGaD
Alendronate—FDPS—Metabolism—L2HGDH—epilepsy syndrome	0.000443	0.00305	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000438	0.00302	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CPSF4—epilepsy syndrome	0.000427	0.00294	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—GBE1—epilepsy syndrome	0.000427	0.00294	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PPP1R3C—epilepsy syndrome	0.000427	0.00294	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.000424	0.00292	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PRDM4—epilepsy syndrome	0.000424	0.00292	CbGpPWpGaD
Alendronate—Dysgeusia—Pregabalin—epilepsy syndrome	0.00041	0.000715	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	0.00041	0.000714	CcSEcCtD
Alendronate—Urticaria—Phenytoin—epilepsy syndrome	0.00041	0.000714	CcSEcCtD
Alendronate—Pruritus—Vigabatrin—epilepsy syndrome	0.000409	0.000712	CcSEcCtD
Alendronate—Asthenia—Diazepam—epilepsy syndrome	0.000408	0.000711	CcSEcCtD
Alendronate—Body temperature increased—Phenytoin—epilepsy syndrome	0.000408	0.00071	CcSEcCtD
Alendronate—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000408	0.00071	CcSEcCtD
Alendronate—Pain—Lamotrigine—epilepsy syndrome	0.000407	0.000709	CcSEcCtD
Alendronate—Constipation—Lamotrigine—epilepsy syndrome	0.000407	0.000709	CcSEcCtD
Alendronate—Nausea—Acetazolamide—epilepsy syndrome	0.000407	0.000708	CcSEcCtD
Alendronate—Dizziness—Levetiracetam—epilepsy syndrome	0.000406	0.000707	CcSEcCtD
Alendronate—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000406	0.000707	CcSEcCtD
Alendronate—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000406	0.000707	CcSEcCtD
Alendronate—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000406	0.000707	CcSEcCtD
Alendronate—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000406	0.000706	CcSEcCtD
Alendronate—FDPS—Metabolism—EPM2A—epilepsy syndrome	0.000405	0.00279	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PNPO—epilepsy syndrome	0.000405	0.00279	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NHLRC1—epilepsy syndrome	0.000405	0.00279	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GAMT—epilepsy syndrome	0.000405	0.00279	CbGpPWpGaD
Alendronate—Vomiting—Propofol—epilepsy syndrome	0.000404	0.000704	CcSEcCtD
Alendronate—Stomatitis—Topiramate—epilepsy syndrome	0.000403	0.000702	CcSEcCtD
Alendronate—Muscle spasms—Pregabalin—epilepsy syndrome	0.000403	0.000702	CcSEcCtD
Alendronate—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000403	0.000701	CcSEcCtD
Alendronate—Pruritus—Diazepam—epilepsy syndrome	0.000403	0.000701	CcSEcCtD
Alendronate—Rash—Propofol—epilepsy syndrome	0.000401	0.000698	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000401	0.00276	CbGpPWpGaD
Alendronate—Dermatitis—Propofol—epilepsy syndrome	0.000401	0.000697	CcSEcCtD
Alendronate—Headache—Propofol—epilepsy syndrome	0.000398	0.000694	CcSEcCtD
Alendronate—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000397	0.000692	CcSEcCtD
Alendronate—Vomiting—Midazolam—epilepsy syndrome	0.000396	0.000689	CcSEcCtD
Alendronate—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000395	0.000689	CcSEcCtD
Alendronate—Asthenia—Felbamate—epilepsy syndrome	0.000395	0.000688	CcSEcCtD
Alendronate—Myalgia—Valproic Acid—epilepsy syndrome	0.000395	0.000687	CcSEcCtD
Alendronate—Chest pain—Valproic Acid—epilepsy syndrome	0.000395	0.000687	CcSEcCtD
Alendronate—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000392	0.000683	CcSEcCtD
Alendronate—Rash—Midazolam—epilepsy syndrome	0.000392	0.000683	CcSEcCtD
Alendronate—Dizziness—Fosphenytoin—epilepsy syndrome	0.000392	0.000683	CcSEcCtD
Alendronate—Dermatitis—Midazolam—epilepsy syndrome	0.000392	0.000682	CcSEcCtD
Alendronate—Urticaria—Carbamazepine—epilepsy syndrome	0.000391	0.000681	CcSEcCtD
Alendronate—Vomiting—Levetiracetam—epilepsy syndrome	0.000391	0.00068	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.00039	0.00269	CbGpPWpGaD
Alendronate—Alopecia—Gabapentin—epilepsy syndrome	0.00039	0.000679	CcSEcCtD
Alendronate—Discomfort—Valproic Acid—epilepsy syndrome	0.00039	0.000679	CcSEcCtD
Alendronate—Headache—Midazolam—epilepsy syndrome	0.00039	0.000679	CcSEcCtD
Alendronate—Pruritus—Felbamate—epilepsy syndrome	0.00039	0.000678	CcSEcCtD
Alendronate—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000389	0.000678	CcSEcCtD
Alendronate—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000389	0.000678	CcSEcCtD
Alendronate—Diarrhoea—Diazepam—epilepsy syndrome	0.000389	0.000678	CcSEcCtD
Alendronate—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000389	0.000678	CcSEcCtD
Alendronate—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000389	0.000677	CcSEcCtD
Alendronate—Rash—Levetiracetam—epilepsy syndrome	0.000387	0.000674	CcSEcCtD
Alendronate—Anaemia—Pregabalin—epilepsy syndrome	0.000387	0.000674	CcSEcCtD
Alendronate—Dermatitis—Levetiracetam—epilepsy syndrome	0.000387	0.000674	CcSEcCtD
Alendronate—Asthenia—Zonisamide—epilepsy syndrome	0.000387	0.000673	CcSEcCtD
Alendronate—Headache—Levetiracetam—epilepsy syndrome	0.000385	0.00067	CcSEcCtD
Alendronate—Erythema—Gabapentin—epilepsy syndrome	0.000384	0.000669	CcSEcCtD
Alendronate—Angioedema—Pregabalin—epilepsy syndrome	0.000383	0.000667	CcSEcCtD
Alendronate—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000383	0.000666	CcSEcCtD
Alendronate—Dizziness—Vigabatrin—epilepsy syndrome	0.000382	0.000665	CcSEcCtD
Alendronate—Pruritus—Zonisamide—epilepsy syndrome	0.000381	0.000664	CcSEcCtD
Alendronate—Hypersensitivity—Phenytoin—epilepsy syndrome	0.00038	0.000662	CcSEcCtD
Alendronate—Flatulence—Gabapentin—epilepsy syndrome	0.000379	0.000659	CcSEcCtD
Alendronate—Urticaria—Lamotrigine—epilepsy syndrome	0.000378	0.000659	CcSEcCtD
Alendronate—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000378	0.000659	CcSEcCtD
Alendronate—Malaise—Pregabalin—epilepsy syndrome	0.000378	0.000658	CcSEcCtD
Alendronate—Nausea—Propofol—epilepsy syndrome	0.000378	0.000658	CcSEcCtD
Alendronate—Vomiting—Fosphenytoin—epilepsy syndrome	0.000377	0.000656	CcSEcCtD
Alendronate—FDPS—Metabolism—QDPR—epilepsy syndrome	0.000377	0.0026	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CA4—epilepsy syndrome	0.000377	0.0026	CbGpPWpGaD
Alendronate—Diarrhoea—Felbamate—epilepsy syndrome	0.000377	0.000656	CcSEcCtD
Alendronate—Vertigo—Pregabalin—epilepsy syndrome	0.000376	0.000656	CcSEcCtD
Alendronate—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000376	0.000655	CcSEcCtD
Alendronate—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000376	0.000655	CcSEcCtD
Alendronate—Dysgeusia—Gabapentin—epilepsy syndrome	0.000376	0.000655	CcSEcCtD
Alendronate—Dizziness—Diazepam—epilepsy syndrome	0.000376	0.000655	CcSEcCtD
Alendronate—Infection—Valproic Acid—epilepsy syndrome	0.000376	0.000654	CcSEcCtD
Alendronate—Rash—Fosphenytoin—epilepsy syndrome	0.000374	0.000651	CcSEcCtD
Alendronate—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000373	0.00065	CcSEcCtD
Alendronate—Haemoglobin—Topiramate—epilepsy syndrome	0.000373	0.00065	CcSEcCtD
Alendronate—Asthenia—Clonazepam—epilepsy syndrome	0.000373	0.000649	CcSEcCtD
Alendronate—Headache—Fosphenytoin—epilepsy syndrome	0.000371	0.000647	CcSEcCtD
Alendronate—Haemorrhage—Topiramate—epilepsy syndrome	0.000371	0.000647	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—ACKR4—epilepsy syndrome	0.000371	0.00255	CbGpPWpGaD
Alendronate—Asthenia—Phenytoin—epilepsy syndrome	0.00037	0.000645	CcSEcCtD
Alendronate—Nausea—Midazolam—epilepsy syndrome	0.00037	0.000643	CcSEcCtD
Alendronate—Muscle spasms—Gabapentin—epilepsy syndrome	0.000369	0.000643	CcSEcCtD
Alendronate—Diarrhoea—Zonisamide—epilepsy syndrome	0.000369	0.000642	CcSEcCtD
Alendronate—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000368	0.000641	CcSEcCtD
Alendronate—Pruritus—Clonazepam—epilepsy syndrome	0.000368	0.00064	CcSEcCtD
Alendronate—Vomiting—Vigabatrin—epilepsy syndrome	0.000367	0.00064	CcSEcCtD
Alendronate—Oedema peripheral—Topiramate—epilepsy syndrome	0.000366	0.000637	CcSEcCtD
Alendronate—Pruritus—Phenytoin—epilepsy syndrome	0.000365	0.000636	CcSEcCtD
Alendronate—Nausea—Levetiracetam—epilepsy syndrome	0.000365	0.000635	CcSEcCtD
Alendronate—Rash—Vigabatrin—epilepsy syndrome	0.000364	0.000635	CcSEcCtD
Alendronate—Dizziness—Felbamate—epilepsy syndrome	0.000364	0.000634	CcSEcCtD
Alendronate—Dermatitis—Vigabatrin—epilepsy syndrome	0.000364	0.000634	CcSEcCtD
Alendronate—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000363	0.000632	CcSEcCtD
Alendronate—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000363	0.000632	CcSEcCtD
Alendronate—Headache—Vigabatrin—epilepsy syndrome	0.000362	0.00063	CcSEcCtD
Alendronate—Vomiting—Diazepam—epilepsy syndrome	0.000362	0.00063	CcSEcCtD
Alendronate—Rash—Diazepam—epilepsy syndrome	0.000359	0.000625	CcSEcCtD
Alendronate—Dermatitis—Diazepam—epilepsy syndrome	0.000358	0.000624	CcSEcCtD
Alendronate—Myalgia—Pregabalin—epilepsy syndrome	0.000357	0.000621	CcSEcCtD
Alendronate—Chest pain—Pregabalin—epilepsy syndrome	0.000357	0.000621	CcSEcCtD
Alendronate—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000357	0.000621	CcSEcCtD
Alendronate—Dizziness—Zonisamide—epilepsy syndrome	0.000356	0.000621	CcSEcCtD
Alendronate—Headache—Diazepam—epilepsy syndrome	0.000356	0.000621	CcSEcCtD
Alendronate—Diarrhoea—Clonazepam—epilepsy syndrome	0.000355	0.000619	CcSEcCtD
Alendronate—Anaemia—Gabapentin—epilepsy syndrome	0.000355	0.000618	CcSEcCtD
Alendronate—ATP6V1A—Disease—ST3GAL3—epilepsy syndrome	0.000355	0.00245	CbGpPWpGaD
Alendronate—FDPS—Metabolism—COX3—epilepsy syndrome	0.000354	0.00244	CbGpPWpGaD
Alendronate—Asthenia—Carbamazepine—epilepsy syndrome	0.000353	0.000615	CcSEcCtD
Alendronate—Diarrhoea—Phenytoin—epilepsy syndrome	0.000353	0.000615	CcSEcCtD
Alendronate—Discomfort—Pregabalin—epilepsy syndrome	0.000352	0.000614	CcSEcCtD
Alendronate—Nausea—Fosphenytoin—epilepsy syndrome	0.000352	0.000613	CcSEcCtD
Alendronate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000351	0.000612	CcSEcCtD
Alendronate—Erythema multiforme—Topiramate—epilepsy syndrome	0.000351	0.000611	CcSEcCtD
Alendronate—Angioedema—Gabapentin—epilepsy syndrome	0.000351	0.000611	CcSEcCtD
Alendronate—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000351	0.000611	CcSEcCtD
Alendronate—Vomiting—Felbamate—epilepsy syndrome	0.00035	0.00061	CcSEcCtD
Alendronate—Pruritus—Carbamazepine—epilepsy syndrome	0.000348	0.000607	CcSEcCtD
Alendronate—Rash—Felbamate—epilepsy syndrome	0.000347	0.000605	CcSEcCtD
Alendronate—Dermatitis—Felbamate—epilepsy syndrome	0.000347	0.000604	CcSEcCtD
Alendronate—Malaise—Gabapentin—epilepsy syndrome	0.000347	0.000603	CcSEcCtD
Alendronate—Vertigo—Gabapentin—epilepsy syndrome	0.000345	0.000601	CcSEcCtD
Alendronate—Headache—Felbamate—epilepsy syndrome	0.000345	0.000601	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000345	0.0006	CcSEcCtD
Alendronate—Dizziness—Clonazepam—epilepsy syndrome	0.000344	0.000598	CcSEcCtD
Alendronate—Nausea—Vigabatrin—epilepsy syndrome	0.000343	0.000598	CcSEcCtD
Alendronate—Vomiting—Zonisamide—epilepsy syndrome	0.000343	0.000597	CcSEcCtD
Alendronate—Asthenia—Lamotrigine—epilepsy syndrome	0.000342	0.000595	CcSEcCtD
Alendronate—Dizziness—Phenytoin—epilepsy syndrome	0.000341	0.000594	CcSEcCtD
Alendronate—Rash—Zonisamide—epilepsy syndrome	0.00034	0.000592	CcSEcCtD
Alendronate—Infection—Pregabalin—epilepsy syndrome	0.00034	0.000592	CcSEcCtD
Alendronate—Dermatitis—Zonisamide—epilepsy syndrome	0.00034	0.000591	CcSEcCtD
Alendronate—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000339	0.000591	CcSEcCtD
Alendronate—Nausea—Diazepam—epilepsy syndrome	0.000338	0.000588	CcSEcCtD
Alendronate—Headache—Zonisamide—epilepsy syndrome	0.000338	0.000588	CcSEcCtD
Alendronate—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000337	0.000587	CcSEcCtD
Alendronate—Pruritus—Lamotrigine—epilepsy syndrome	0.000337	0.000586	CcSEcCtD
Alendronate—FDPS—Metabolism—SLCO1A2—epilepsy syndrome	0.000336	0.00232	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CACNA2D2—epilepsy syndrome	0.000336	0.00232	CbGpPWpGaD
Alendronate—FDPS—Metabolism—KCNB1—epilepsy syndrome	0.000336	0.00232	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PFKL—epilepsy syndrome	0.000336	0.00232	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SLC6A8—epilepsy syndrome	0.000336	0.00232	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SSTR5—epilepsy syndrome	0.000335	0.00231	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SSTR4—epilepsy syndrome	0.000335	0.00231	CbGpPWpGaD
Alendronate—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000333	0.00058	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000332	0.00229	CbGpPWpGaD
Alendronate—Vomiting—Clonazepam—epilepsy syndrome	0.00033	0.000575	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	0.000328	0.00226	CbGpPWpGaD
Alendronate—Alopecia—Topiramate—epilepsy syndrome	0.000328	0.000571	CcSEcCtD
Alendronate—Vomiting—Phenytoin—epilepsy syndrome	0.000328	0.000571	CcSEcCtD
Alendronate—Rash—Clonazepam—epilepsy syndrome	0.000328	0.00057	CcSEcCtD
Alendronate—Dermatitis—Clonazepam—epilepsy syndrome	0.000327	0.00057	CcSEcCtD
Alendronate—Chest pain—Gabapentin—epilepsy syndrome	0.000327	0.00057	CcSEcCtD
Alendronate—Myalgia—Gabapentin—epilepsy syndrome	0.000327	0.00057	CcSEcCtD
Alendronate—Nausea—Felbamate—epilepsy syndrome	0.000327	0.00057	CcSEcCtD
Alendronate—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000326	0.000568	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	0.000326	0.00225	CbGpPWpGaD
Alendronate—Dizziness—Carbamazepine—epilepsy syndrome	0.000326	0.000567	CcSEcCtD
Alendronate—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000326	0.000567	CcSEcCtD
Alendronate—Headache—Clonazepam—epilepsy syndrome	0.000325	0.000567	CcSEcCtD
Alendronate—Rash—Phenytoin—epilepsy syndrome	0.000325	0.000567	CcSEcCtD
Alendronate—Dermatitis—Phenytoin—epilepsy syndrome	0.000325	0.000566	CcSEcCtD
Alendronate—Rash—Oxcarbazepine—epilepsy syndrome	0.000324	0.000564	CcSEcCtD
Alendronate—Pain—Valproic Acid—epilepsy syndrome	0.000323	0.000563	CcSEcCtD
Alendronate—Constipation—Valproic Acid—epilepsy syndrome	0.000323	0.000563	CcSEcCtD
Alendronate—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000323	0.000563	CcSEcCtD
Alendronate—Headache—Phenytoin—epilepsy syndrome	0.000323	0.000563	CcSEcCtD
Alendronate—Erythema—Topiramate—epilepsy syndrome	0.000323	0.000563	CcSEcCtD
Alendronate—Discomfort—Gabapentin—epilepsy syndrome	0.000323	0.000563	CcSEcCtD
Alendronate—Headache—Oxcarbazepine—epilepsy syndrome	0.000322	0.00056	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CCR10—epilepsy syndrome	0.000321	0.00221	CbGpPWpGaD
Alendronate—Nausea—Zonisamide—epilepsy syndrome	0.00032	0.000558	CcSEcCtD
Alendronate—Flatulence—Topiramate—epilepsy syndrome	0.000319	0.000555	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000317	0.00218	CbGpPWpGaD
Alendronate—Dysgeusia—Topiramate—epilepsy syndrome	0.000317	0.000551	CcSEcCtD
Alendronate—Dizziness—Lamotrigine—epilepsy syndrome	0.000315	0.000548	CcSEcCtD
Alendronate—Vomiting—Carbamazepine—epilepsy syndrome	0.000313	0.000545	CcSEcCtD
Alendronate—FDPS—SREBP signalling—AKT1—epilepsy syndrome	0.000313	0.00216	CbGpPWpGaD
Alendronate—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000312	0.000543	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000312	0.000543	CcSEcCtD
Alendronate—Infection—Gabapentin—epilepsy syndrome	0.000312	0.000543	CcSEcCtD
Alendronate—Muscle spasms—Topiramate—epilepsy syndrome	0.000311	0.000541	CcSEcCtD
Alendronate—Rash—Carbamazepine—epilepsy syndrome	0.000311	0.000541	CcSEcCtD
Alendronate—Dermatitis—Carbamazepine—epilepsy syndrome	0.00031	0.00054	CcSEcCtD
Alendronate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000309	0.000539	CcSEcCtD
Alendronate—Nausea—Clonazepam—epilepsy syndrome	0.000309	0.000537	CcSEcCtD
Alendronate—Headache—Carbamazepine—epilepsy syndrome	0.000309	0.000537	CcSEcCtD
Alendronate—FDPS—Metabolism—NEU1—epilepsy syndrome	0.000307	0.00212	CbGpPWpGaD
Alendronate—FDPS—Metabolism—UPB1—epilepsy syndrome	0.000307	0.00212	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ATIC—epilepsy syndrome	0.000307	0.00212	CbGpPWpGaD
Alendronate—Nausea—Phenytoin—epilepsy syndrome	0.000307	0.000534	CcSEcCtD
Alendronate—Nausea—Oxcarbazepine—epilepsy syndrome	0.000305	0.000531	CcSEcCtD
Alendronate—Vomiting—Lamotrigine—epilepsy syndrome	0.000303	0.000527	CcSEcCtD
Alendronate—Urticaria—Valproic Acid—epilepsy syndrome	0.000301	0.000523	CcSEcCtD
Alendronate—Rash—Lamotrigine—epilepsy syndrome	0.0003	0.000523	CcSEcCtD
Alendronate—Ill-defined disorder—Topiramate—epilepsy syndrome	0.0003	0.000522	CcSEcCtD
Alendronate—Dermatitis—Lamotrigine—epilepsy syndrome	0.0003	0.000522	CcSEcCtD
Alendronate—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000299	0.000521	CcSEcCtD
Alendronate—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000299	0.000521	CcSEcCtD
Alendronate—Anaemia—Topiramate—epilepsy syndrome	0.000299	0.00052	CcSEcCtD
Alendronate—Headache—Lamotrigine—epilepsy syndrome	0.000298	0.000519	CcSEcCtD
Alendronate—FDPS—Metabolism—HSD17B4—epilepsy syndrome	0.000296	0.00204	CbGpPWpGaD
Alendronate—Nausea—Carbamazepine—epilepsy syndrome	0.000293	0.000509	CcSEcCtD
Alendronate—Constipation—Pregabalin—epilepsy syndrome	0.000292	0.000509	CcSEcCtD
Alendronate—Pain—Pregabalin—epilepsy syndrome	0.000292	0.000509	CcSEcCtD
Alendronate—Malaise—Topiramate—epilepsy syndrome	0.000292	0.000508	CcSEcCtD
Alendronate—Vertigo—Topiramate—epilepsy syndrome	0.00029	0.000506	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000286	0.000498	CcSEcCtD
Alendronate—FDPS—Metabolism—GBE1—epilepsy syndrome	0.000286	0.00197	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPP1R3C—epilepsy syndrome	0.000286	0.00197	CbGpPWpGaD
Alendronate—Nausea—Lamotrigine—epilepsy syndrome	0.000283	0.000492	CcSEcCtD
Alendronate—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000282	0.000491	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—GRM2—epilepsy syndrome	0.000281	0.00194	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.00028	0.000487	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	0.000279	0.00192	CbGpPWpGaD
Alendronate—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000279	0.000485	CcSEcCtD
Alendronate—Dyspepsia—Gabapentin—epilepsy syndrome	0.000276	0.000481	CcSEcCtD
Alendronate—Myalgia—Topiramate—epilepsy syndrome	0.000275	0.000479	CcSEcCtD
Alendronate—Chest pain—Topiramate—epilepsy syndrome	0.000275	0.000479	CcSEcCtD
Alendronate—Discomfort—Topiramate—epilepsy syndrome	0.000272	0.000473	CcSEcCtD
Alendronate—Urticaria—Pregabalin—epilepsy syndrome	0.000272	0.000473	CcSEcCtD
Alendronate—Asthenia—Valproic Acid—epilepsy syndrome	0.000271	0.000473	CcSEcCtD
Alendronate—Abdominal pain—Pregabalin—epilepsy syndrome	0.00027	0.000471	CcSEcCtD
Alendronate—Body temperature increased—Pregabalin—epilepsy syndrome	0.00027	0.000471	CcSEcCtD
Alendronate—FDPS—Metabolism—ASAH1—epilepsy syndrome	0.000269	0.00185	CbGpPWpGaD
Alendronate—Pain—Gabapentin—epilepsy syndrome	0.000268	0.000467	CcSEcCtD
Alendronate—Constipation—Gabapentin—epilepsy syndrome	0.000268	0.000467	CcSEcCtD
Alendronate—Pruritus—Valproic Acid—epilepsy syndrome	0.000268	0.000466	CcSEcCtD
Alendronate—Infection—Topiramate—epilepsy syndrome	0.000262	0.000456	CcSEcCtD
Alendronate—FDPS—Metabolism—STXBP1—epilepsy syndrome	0.000261	0.0018	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000261	0.0018	CbGpPWpGaD
Alendronate—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000259	0.000451	CcSEcCtD
Alendronate—ATP6V1A—Disease—EIF2AK2—epilepsy syndrome	0.000258	0.00178	CbGpPWpGaD
Alendronate—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000258	0.00045	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000258	0.00178	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000256	0.000447	CcSEcCtD
Alendronate—FDPS—Metabolism—ALAD—epilepsy syndrome	0.000255	0.00175	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NT5E—epilepsy syndrome	0.000255	0.00175	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SSTR3—epilepsy syndrome	0.000254	0.00175	CbGpPWpGaD
Alendronate—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000252	0.000439	CcSEcCtD
Alendronate—Dizziness—Valproic Acid—epilepsy syndrome	0.00025	0.000436	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.00025	0.00172	CbGpPWpGaD
Alendronate—Urticaria—Gabapentin—epilepsy syndrome	0.000249	0.000434	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000249	0.00171	CbGpPWpGaD
Alendronate—Body temperature increased—Gabapentin—epilepsy syndrome	0.000248	0.000432	CcSEcCtD
Alendronate—Abdominal pain—Gabapentin—epilepsy syndrome	0.000248	0.000432	CcSEcCtD
Alendronate—Asthenia—Pregabalin—epilepsy syndrome	0.000245	0.000427	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000244	0.00168	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCR9—epilepsy syndrome	0.000244	0.00168	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NPY2R—epilepsy syndrome	0.000244	0.00168	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCR8—epilepsy syndrome	0.000244	0.00168	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SSTR1—epilepsy syndrome	0.000244	0.00168	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALDH7A1—epilepsy syndrome	0.000243	0.00167	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CACNA1A—epilepsy syndrome	0.000243	0.00167	CbGpPWpGaD
Alendronate—Pruritus—Pregabalin—epilepsy syndrome	0.000242	0.000421	CcSEcCtD
Alendronate—Vomiting—Valproic Acid—epilepsy syndrome	0.000241	0.000419	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.00024	0.000419	CcSEcCtD
Alendronate—ATP6V1A—Disease—PPIA—epilepsy syndrome	0.000239	0.00165	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GRM3—epilepsy syndrome	0.000239	0.00165	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GRM4—epilepsy syndrome	0.000239	0.00165	CbGpPWpGaD
Alendronate—Rash—Valproic Acid—epilepsy syndrome	0.000239	0.000415	CcSEcCtD
Alendronate—Dermatitis—Valproic Acid—epilepsy syndrome	0.000238	0.000415	CcSEcCtD
Alendronate—FDPS—Metabolism—ST3GAL3—epilepsy syndrome	0.000238	0.00164	CbGpPWpGaD
Alendronate—Headache—Valproic Acid—epilepsy syndrome	0.000237	0.000413	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—DUSP4—epilepsy syndrome	0.000234	0.00162	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SSTR2—epilepsy syndrome	0.000234	0.00162	CbGpPWpGaD
Alendronate—Diarrhoea—Pregabalin—epilepsy syndrome	0.000234	0.000407	CcSEcCtD
Alendronate—FDPS—Metabolism—ADSL—epilepsy syndrome	0.000233	0.0016	CbGpPWpGaD
Alendronate—Dyspepsia—Topiramate—epilepsy syndrome	0.000232	0.000404	CcSEcCtD
Alendronate—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000231	0.000402	CcSEcCtD
Alendronate—FDPS—Metabolism—GLUL—epilepsy syndrome	0.000228	0.00157	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GRM8—epilepsy syndrome	0.000226	0.00156	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PGF—epilepsy syndrome	0.000226	0.00156	CbGpPWpGaD
Alendronate—Dizziness—Pregabalin—epilepsy syndrome	0.000226	0.000394	CcSEcCtD
Alendronate—Pain—Topiramate—epilepsy syndrome	0.000226	0.000393	CcSEcCtD
Alendronate—Constipation—Topiramate—epilepsy syndrome	0.000226	0.000393	CcSEcCtD
Alendronate—Asthenia—Gabapentin—epilepsy syndrome	0.000225	0.000392	CcSEcCtD
Alendronate—Nausea—Valproic Acid—epilepsy syndrome	0.000225	0.000391	CcSEcCtD
Alendronate—FDPS—Metabolism—CACNA1D—epilepsy syndrome	0.000224	0.00154	CbGpPWpGaD
Alendronate—Pruritus—Gabapentin—epilepsy syndrome	0.000222	0.000386	CcSEcCtD
Alendronate—Vomiting—Pregabalin—epilepsy syndrome	0.000217	0.000379	CcSEcCtD
Alendronate—Feeling abnormal—Topiramate—epilepsy syndrome	0.000217	0.000379	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—OPRD1—epilepsy syndrome	0.000216	0.00149	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GNAO1—epilepsy syndrome	0.000216	0.00149	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000216	0.000376	CcSEcCtD
Alendronate—Rash—Pregabalin—epilepsy syndrome	0.000216	0.000375	CcSEcCtD
Alendronate—Dermatitis—Pregabalin—epilepsy syndrome	0.000215	0.000375	CcSEcCtD
Alendronate—Diarrhoea—Gabapentin—epilepsy syndrome	0.000215	0.000374	CcSEcCtD
Alendronate—Headache—Pregabalin—epilepsy syndrome	0.000214	0.000373	CcSEcCtD
Alendronate—FDPS—Metabolism—TXNRD1—epilepsy syndrome	0.00021	0.00144	CbGpPWpGaD
Alendronate—Urticaria—Topiramate—epilepsy syndrome	0.00021	0.000365	CcSEcCtD
Alendronate—Body temperature increased—Topiramate—epilepsy syndrome	0.000209	0.000363	CcSEcCtD
Alendronate—Abdominal pain—Topiramate—epilepsy syndrome	0.000209	0.000363	CcSEcCtD
Alendronate—Dizziness—Gabapentin—epilepsy syndrome	0.000207	0.000361	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PDYN—epilepsy syndrome	0.000207	0.00143	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CHRM1—epilepsy syndrome	0.000207	0.00143	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCR7—epilepsy syndrome	0.000207	0.00143	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GRM1—epilepsy syndrome	0.000207	0.00143	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AQP1—epilepsy syndrome	0.000203	0.0014	CbGpPWpGaD
Alendronate—Nausea—Pregabalin—epilepsy syndrome	0.000203	0.000354	CcSEcCtD
Alendronate—Vomiting—Gabapentin—epilepsy syndrome	0.000199	0.000347	CcSEcCtD
Alendronate—Rash—Gabapentin—epilepsy syndrome	0.000198	0.000344	CcSEcCtD
Alendronate—Dermatitis—Gabapentin—epilepsy syndrome	0.000198	0.000344	CcSEcCtD
Alendronate—Headache—Gabapentin—epilepsy syndrome	0.000196	0.000342	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.000195	0.00135	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GFAP—epilepsy syndrome	0.000195	0.00134	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GAL—epilepsy syndrome	0.000195	0.00134	CbGpPWpGaD
Alendronate—Hypersensitivity—Topiramate—epilepsy syndrome	0.000194	0.000338	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CASP2—epilepsy syndrome	0.000192	0.00133	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CHRM3—epilepsy syndrome	0.000192	0.00133	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GRM5—epilepsy syndrome	0.000192	0.00133	CbGpPWpGaD
Alendronate—Asthenia—Topiramate—epilepsy syndrome	0.000189	0.00033	CcSEcCtD
Alendronate—Pruritus—Topiramate—epilepsy syndrome	0.000187	0.000325	CcSEcCtD
Alendronate—Nausea—Gabapentin—epilepsy syndrome	0.000186	0.000324	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000185	0.00127	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CHRM3—epilepsy syndrome	0.000184	0.00127	CbGpPWpGaD
Alendronate—FDPS—Metabolism—KCNJ11—epilepsy syndrome	0.000184	0.00127	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000181	0.00125	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000181	0.00125	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CHRM2—epilepsy syndrome	0.000181	0.00125	CbGpPWpGaD
Alendronate—Diarrhoea—Topiramate—epilepsy syndrome	0.000181	0.000314	CcSEcCtD
Alendronate—ATP6V1A—Disease—SLC2A1—epilepsy syndrome	0.000177	0.00122	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GABBR1—epilepsy syndrome	0.000176	0.00121	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—JUNB—epilepsy syndrome	0.000176	0.00121	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS1—epilepsy syndrome	0.000175	0.0012	CbGpPWpGaD
Alendronate—Dizziness—Topiramate—epilepsy syndrome	0.000174	0.000304	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	0.000171	0.00118	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HRH3—epilepsy syndrome	0.000169	0.00116	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	0.000168	0.00116	CbGpPWpGaD
Alendronate—Vomiting—Topiramate—epilepsy syndrome	0.000168	0.000292	CcSEcCtD
Alendronate—ATP6V1A—Disease—HBEGF—epilepsy syndrome	0.000167	0.00115	CbGpPWpGaD
Alendronate—Rash—Topiramate—epilepsy syndrome	0.000166	0.00029	CcSEcCtD
Alendronate—Dermatitis—Topiramate—epilepsy syndrome	0.000166	0.000289	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—OPRM1—epilepsy syndrome	0.000166	0.00115	CbGpPWpGaD
Alendronate—Headache—Topiramate—epilepsy syndrome	0.000165	0.000288	CcSEcCtD
Alendronate—ATP6V1A—Disease—AKT3—epilepsy syndrome	0.000163	0.00113	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ADAM10—epilepsy syndrome	0.00016	0.0011	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCR3—epilepsy syndrome	0.000157	0.00108	CbGpPWpGaD
Alendronate—Nausea—Topiramate—epilepsy syndrome	0.000157	0.000273	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ALB—epilepsy syndrome	0.000156	0.00108	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000153	0.00105	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NPY—epilepsy syndrome	0.000153	0.00105	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCG2—epilepsy syndrome	0.00015	0.00103	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CDC42—epilepsy syndrome	0.000149	0.00103	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HSPB1—epilepsy syndrome	0.000148	0.00102	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCL3—epilepsy syndrome	0.000148	0.00102	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—OXT—epilepsy syndrome	0.000148	0.00102	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CRH—epilepsy syndrome	0.000148	0.00102	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCL2—epilepsy syndrome	0.000148	0.00102	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP2C19—epilepsy syndrome	0.000146	0.00101	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP11A1—epilepsy syndrome	0.000145	0.001	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	0.000144	0.000994	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTK2B—epilepsy syndrome	0.000137	0.000945	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TSC1—epilepsy syndrome	0.000137	0.000945	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HES1—epilepsy syndrome	0.000137	0.000941	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NTRK2—epilepsy syndrome	0.000133	0.00092	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCR2—epilepsy syndrome	0.000133	0.00092	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SST—epilepsy syndrome	0.000133	0.00092	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FYN—epilepsy syndrome	0.000133	0.000915	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—H2AFX—epilepsy syndrome	0.000132	0.000912	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—DUSP6—epilepsy syndrome	0.000132	0.000912	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	0.000132	0.000907	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP2D6—epilepsy syndrome	0.000131	0.000904	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000131	0.0009	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PLAT—epilepsy syndrome	0.00013	0.000896	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—YWHAZ—epilepsy syndrome	0.000128	0.00088	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCL12—epilepsy syndrome	0.000125	0.000865	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000125	0.000865	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ADRA2A—epilepsy syndrome	0.000125	0.00086	CbGpPWpGaD
Alendronate—FDPS—Metabolism—BCHE—epilepsy syndrome	0.000124	0.000857	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JUNB—epilepsy syndrome	0.000123	0.000849	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CNR1—epilepsy syndrome	0.000123	0.000849	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CCR5—epilepsy syndrome	0.000123	0.000846	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PLCB1—epilepsy syndrome	0.000123	0.000846	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HTR7—epilepsy syndrome	0.00012	0.000828	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SLC2A1—epilepsy syndrome	0.000119	0.000817	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PLCB1—epilepsy syndrome	0.000117	0.000809	CbGpPWpGaD
Alendronate—FDPS—Metabolism—TH—epilepsy syndrome	0.000117	0.000806	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HBEGF—epilepsy syndrome	0.000117	0.000804	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	0.000115	0.000793	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKT3—epilepsy syndrome	0.000114	0.000789	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TSC2—epilepsy syndrome	0.000114	0.000787	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADAM10—epilepsy syndrome	0.000112	0.000771	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOE—epilepsy syndrome	0.000112	0.00077	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—S100B—epilepsy syndrome	0.000106	0.000729	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6ST—epilepsy syndrome	0.000105	0.000723	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SOCS3—epilepsy syndrome	0.000105	0.000722	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CDC42—epilepsy syndrome	0.000104	0.00072	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS2—epilepsy syndrome	0.000104	0.000717	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AVP—epilepsy syndrome	0.000101	0.000697	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HMOX1—epilepsy syndrome	9.75e-05	0.000672	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CAT—epilepsy syndrome	9.62e-05	0.000663	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HES1—epilepsy syndrome	9.56e-05	0.000659	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCB1—epilepsy syndrome	9.36e-05	0.000645	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FYN—epilepsy syndrome	9.3e-05	0.000641	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—H2AFX—epilepsy syndrome	9.26e-05	0.000639	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MEF2C—epilepsy syndrome	9.25e-05	0.000637	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—YWHAZ—epilepsy syndrome	8.94e-05	0.000616	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NGF—epilepsy syndrome	8.84e-05	0.000609	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GPX1—epilepsy syndrome	8.7e-05	0.0006	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCR5—epilepsy syndrome	8.6e-05	0.000593	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FGF2—epilepsy syndrome	8.49e-05	0.000585	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HTR2A—epilepsy syndrome	8.41e-05	0.00058	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TSC2—epilepsy syndrome	7.99e-05	0.000551	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AGT—epilepsy syndrome	7.98e-05	0.00055	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOE—epilepsy syndrome	7.82e-05	0.000539	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MTOR—epilepsy syndrome	7.72e-05	0.000532	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KDR—epilepsy syndrome	7.66e-05	0.000528	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTGS2—epilepsy syndrome	7.65e-05	0.000528	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AGT—epilepsy syndrome	7.63e-05	0.000526	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOE—epilepsy syndrome	7.48e-05	0.000515	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PRKCB—epilepsy syndrome	7.38e-05	0.000508	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6ST—epilepsy syndrome	7.35e-05	0.000506	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—POMC—epilepsy syndrome	6.72e-05	0.000463	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCL2—epilepsy syndrome	6.57e-05	0.000453	CbGpPWpGaD
Alendronate—FDPS—Metabolism—POMC—epilepsy syndrome	6.42e-05	0.000443	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SRC—epilepsy syndrome	6.19e-05	0.000427	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGF2—epilepsy syndrome	5.94e-05	0.00041	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALB—epilepsy syndrome	5.86e-05	0.000404	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RELA—epilepsy syndrome	5.52e-05	0.00038	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MTOR—epilepsy syndrome	5.41e-05	0.000373	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTGS2—epilepsy syndrome	5.12e-05	0.000353	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CASP3—epilepsy syndrome	4.98e-05	0.000343	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JUN—epilepsy syndrome	4.83e-05	0.000333	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MMP9—epilepsy syndrome	4.7e-05	0.000324	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SRC—epilepsy syndrome	4.33e-05	0.000299	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFA—epilepsy syndrome	4.22e-05	0.000291	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKT1—epilepsy syndrome	3.85e-05	0.000265	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKT1—epilepsy syndrome	2.69e-05	0.000186	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AKT1—epilepsy syndrome	2.58e-05	0.000178	CbGpPWpGaD
